SCHEMBL762648

SCHEMBL762648

COCCCn1c(C2CCCN(C(=O)C[C@@H](Cc3ccc4ccccc4c3)NC(=O)OC(C)(C)C)C2)nc2ccc(O)cc21

nearest known ligand 0.36

Predicted protein targets (top 17)

geneUniProtsupporting neighboursconfidence
HRH1 P35367 6/20 0.36
CYP2D6 P10635 3/20 0.36
CTSB P07858 1/20 0.36
CTSS P25774 1/20 0.36
CTSK P43235 1/20 0.36
KCNH2 Q12809 6/20 0.36
PADI4 Q9UM07 2/20 0.36
CHRM1 P11229 1/20 0.35
KLK5 Q9Y337 1/20 0.34
PPIA P62937 2/20 0.34
HRH2 P25021 1/20 0.33
ADORA2A P29274 1/20 0.33
TACR1 P25103 1/20 0.33
CYP3A4 P08684 1/20 0.33
GHSR Q92847 1/20 0.33
ACE P12821 1/20 0.32
PTPN1 P18031 1/20 0.32

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL762559 0.94 KCNH2 (0.39) HRH1CYP2D6CTSBCTSSCTSK
SCHEMBL762577 0.94 CTSB (0.36) HRH1CYP2D6CTSBCTSSCTSK
SCHEMBL762785 0.94 HRH1 (0.42) HRH1CYP2D6CTSBCTSSCTSK
SCHEMBL762657 0.93 PPARA (0.36) HRH1CYP2D6CTSBCTSSCTSK
SCHEMBL763206 0.93 HRH1 (0.40) HRH1CYP2D6CTSBCTSSCTSK
SCHEMBL762513 0.93 KCNH2 (0.36) HRH1CYP2D6CTSBCTSSCTSK
SCHEMBL741447 0.92 ADORA2A (0.36) HRH1CYP2D6CTSBCTSSCTSK
SCHEMBL741446 0.92 ADORA2A (0.36) HRH1CYP2D6CTSBCTSSCTSK
SCHEMBL763244 0.91 ADORA2A (0.41) HRH1CYP2D6CTSBCTSSCTSK
SCHEMBL762582 0.91 CASR (0.37) HRH1CYP2D6CTSBCTSSCTSK

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 2 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-8138168-B1 Renin inhibitors TAKEDA PHARMACEUTICAL COMPANY LIMITED (JP) 2012-03-20 US disclosed
US-8138168-B1 Renin inhibitors TAKEDA PHARMACEUTICAL COMPANY LIMITED (JP) 2012-03-20 US disclosed